Free Trial

Scilex (SCLX) News Today

Scilex logo
$0.45 +0.01 (+1.64%)
(As of 12/20/2024 05:31 PM ET)
Scilex Holding (NASDAQ:SCLX) Insider Acquires $13,800.00 in Stock
Scilex Holding stock logo
Jaisim Shah Purchases 30,000 Shares of Scilex Holding (NASDAQ:SCLX) Stock
Scilex Holding (NASDAQ:SCLX - Get Free Report) insider Jaisim Shah bought 30,000 shares of the stock in a transaction on Wednesday, December 18th. The shares were acquired at an average cost of $0.46 per share, for a total transaction of $13,800.00. Following the purchase, the insider now owns 139,333 shares in the company, valued at approximately $64,093.18. This represents a 27.44 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.
Scilex Holding Company (SCLXW)
Scilex Holding stock logo
Short Interest in Scilex Holding (NASDAQ:SCLX) Declines By 51.1%
Scilex Holding (NASDAQ:SCLX - Get Free Report) saw a significant decline in short interest in November. As of November 15th, there was short interest totalling 5,400,000 shares, a decline of 51.1% from the October 31st total of 11,040,000 shares. Based on an average daily volume of 1,970,000 shares, the days-to-cover ratio is presently 2.7 days. Currently, 4.2% of the shares of the company are sold short.
Scilex Holding Plans Merger to Boost Semnur Value
Scilex announces successful end of Phase II meeting with FDA
Scilex Holding stock logo
Jaisim Shah Acquires 32,000 Shares of Scilex Holding (NASDAQ:SCLX) Stock
Scilex Holding (NASDAQ:SCLX - Get Free Report) insider Jaisim Shah purchased 32,000 shares of the company's stock in a transaction dated Tuesday, October 29th. The stock was purchased at an average cost of $0.99 per share, with a total value of $31,680.00. Following the purchase, the insider now owns 109,333 shares in the company, valued at approximately $108,239.67. This trade represents a 0.00 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.
Scilex Holding stock logo
What is HC Wainwright's Forecast for Scilex Q3 Earnings?
Scilex Holding (NASDAQ:SCLX - Free Report) - Equities research analysts at HC Wainwright issued their Q3 2024 earnings per share (EPS) estimates for shares of Scilex in a report released on Monday, October 21st. HC Wainwright analyst R. Selvaraju expects that the company will post earnings of ($0
Scilex Holding stock logo
Scilex (NASDAQ:SCLX) Stock Rating Reaffirmed by HC Wainwright
HC Wainwright reiterated a "buy" rating and set a $7.00 price target on shares of Scilex in a report on Monday.
Scilex Holding stock logo
Scilex Holding (NASDAQ:SCLX) Insider Buys $29,700.00 in Stock
Scilex Holding (NASDAQ:SCLX - Get Free Report) insider Jaisim Shah bought 30,000 shares of the stock in a transaction on Wednesday, October 16th. The stock was acquired at an average price of $0.99 per share, with a total value of $29,700.00. Following the completion of the acquisition, the insider now owns 77,333 shares of the company's stock, valued at $76,559.67. This represents a 0.00 % increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.
Scilex Holding To Explore Ways To Maximize Value Scilex Pharma.
Scilex Holding stock logo
Scilex (NASDAQ:SCLX) Now Covered by Analysts at Alliance Global Partners
Alliance Global Partners began coverage on shares of Scilex in a research report on Wednesday. They issued a "buy" rating and a $14.00 price target on the stock.
SCLX Grows Sales and Improves Finances
Scilex Holding stock logo
Armistice Capital LLC Invests $23.06 Million in Scilex Holding (NASDAQ:SCLX)
Armistice Capital LLC acquired a new stake in Scilex Holding (NASDAQ:SCLX - Free Report) in the second quarter, according to the company in its most recent filing with the SEC. The firm acquired 11,950,000 shares of the company's stock, valued at approximately $23,064,000. Armistice Capital LLC own
SCLX Makes Move to Boost Shareholder Value
Scilex Announces FDA Approval Of SNDA For Label Updates To Gloperba
Scilex Holding stock logo
Q3 2024 EPS Estimates for Scilex Holding Reduced by Zacks Small Cap (NASDAQ:SCLX)
Scilex Holding (NASDAQ:SCLX - Free Report) - Equities researchers at Zacks Small Cap reduced their Q3 2024 earnings per share (EPS) estimates for shares of Scilex in a note issued to investors on Wednesday, August 14th. Zacks Small Cap analyst B. Sorensen now forecasts that the company will post
Scilex Holding stock logo
Scilex (NASDAQ:SCLX) Shares Down 0.8%
Scilex (NASDAQ:SCLX) Stock Price Down 0.8%
Get Scilex News Delivered to You Automatically

Sign up to receive the latest news and ratings for SCLX and its competitors with MarketBeat's FREE daily newsletter.

70%, 80%, 90% Win Rates? Grab Your Free Cheatsheets Today! (Ad)

Would you like to know the historic win rate of every trade you take before you place it? Well, it’s all possible with these FIVE Candlestick Pattern Cheatsheets.

>> You can grab your FREE, laminated copies right here << 

SCLX Media Mentions By Week

SCLX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

SCLX
News Sentiment

0.80

0.60

Average
Medical
News Sentiment

SCLX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

SCLX Articles
This Week

5

2

SCLX Articles
Average Week

Get Scilex News Delivered to You Automatically

Sign up to receive the latest news and ratings for SCLX and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:SCLX) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners